1. Posso M, Alcántara R, Vosges I, Comerma L, Baré M, Louro J, Quintana MJ, Román M, Marcos-Gragera R, Vernet-Tomas M, Saladie F, Vidal C, Bargalló X, Peñalva L, Sala M, Castells X; BELE study group. Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening. Eur Radiol. 2022;32:621-29. doi: 10.1007/s00330-021-08118-y. PMID: 34156554.


2. Salinas-Huertas S, Luzardo-González A, Vázquez-Gallego S, Pernas S, Falo C, Pla MJ, Gil-Gil M, Beranuy-Rodriguez M, Pérez-Montero H, Gomila-Sancho M, Manent-Molina N, Arencibia-Domínguez A, Gonzalez-Pineda B, Tormo-Collado F, Ortí-Asencio M, Terra J, Martinez-Perez E, Mestre-Jane A, Campos-Varela I, Jaraba-Armas M, Benítez-Segura A, Campos-Delgado M, Fernández-Montolí ME, Valverde-Alcántara Y, Rodríguez A, Campos G, Guma A, Ponce-Sebastià J, Planas-Balagué R, Catasús-Clavé M, García-Tejedor A. Risk factors for lymphedema after breast surgery: A prospective cohort study in the era of sentinel lymph node biopsy. Breast Dis. 2022;41:97-108. doi: 10.3233/BD-210043. PMID: 34542055.


3. Hernández-García M, Molina-Barceló A, Vanaclocha-Espí M, Zurriaga O, Pérez B, Aragonés N, Amiano P, Altzibar JM, Castaño-Vinyals G, Sala M, Ederra M, Martín V, Gómez-Acebo I, Vidal C, Tardón A, Marcos-Gragera R, Pollán M, Kogevinas M, Salas D.  Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study). Cancer Causes Control. 2022;33;125-36. doi: 10.1007/s10552-021-01511-4. PMID: 34817770.


4. Valli C, Suñol R, Orrego C, Niño de Guzmán E, Strammiello V, Adrion N, Immonen K, Ninov L, van der Gaag M, Ballester M, Alonso-Coello P. The development of a core outcome set for self-management interventions for patients living with obesity. Clin Obes. 2022;12:e12489. doi: 10.1111/cob.12489. PMID: 34617681.


5. Vives N, Binefa G, Vidal C, Milà N, Muñoz R, Guardiola V, Rial O, Garcia M. Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain). Prev Med. 2022;155: 106929. doi: 10.1016/j.ypmed.2021.106929. PMID: 34954239


6. Hernández-Leal MJ, Codern-Bové N, Pérez-Lacasta MJ, Cardona A, Vidal-Lancis C, Carles-Lavila M; ProShare Group. Development of support material for health professionals who are implementing Shared Decision-making in breast cancer screening: validation using the Delphi technique. BMJ Open. 2022;12(2):e052566. doi: 10.1136/bmjopen-2021-052566. PMID: 35105575.


7. Ibáñez-Sanz G, Milà N, Vives N, Vidal C, Binefa G, Rocamora J, Atencia C, Moreno V, Sanz-Pamplona R, Garcia M, on behalf of the MSIC-SC Research Group. Diagnostic Performance of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program According to Ambient Temperature and Humidity. Cancers. 2022; 14(5):1153. doi.org/10.3390/cancers14051153. PMID: 35267461.


8. Román M, Louro J, Posso M, Vidal C, Bargalló X, Vázquez I, Quintana MJ, Alcántara R, Saladié F, Del Riesgo J, Peñalva L, Sala M, Castells X. Long-term risk of breast cancer after diagnosis of benign breast disease by screening mammography. Int J Environ Res Public Health. 2022;19(5): 2625. doi.org/10.3390/ijerph19052625. PMID: 35270331.


9. van Wifferen F, de Jonge L, Worthington J, Greuter MJE, Lew JB, Nadeau C, van den Puttelaar R, Feletto E, Yong JHE, Lansdorp-Vogelaar I, Canfell K, Coupé VMH on behalf of the COVID-19 and Cancer Global Modelling Consortium (CCGMC) working group. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study. J Med Screen. 2022;29:72-83. doi: 10.1177/09691413211056777. PMID: 35100894.


10. Ibáñez-Sanz G, Sanz-Pamplona R, Garcia M on behalf of the MSIC-SC research group. Post-polypectomy colonoscopy surveillance: Can we improve the diagnostic yield? Gastroenterol Hepatol. 2022;45:474-87. doi: 10.1016/j.gastrohep.2021.11.005. PMID: 34848307.


11. Ochoa-Arnedo C, Prats C, Travier N, Marques-Feixa L, Flix-Valle A, de Frutos ML, Domingo-Gil E, Medina JC, Serra-Blasco M. Stressful Life Events and Distress in Breast Cancer: A 5-Years Follow-Up. Int J Clin Health Psychol. 2022;22(2):100303. doi: 10.1016/j.ijchp.2022.100303. PMID: 35572072.


12. Pérez-Bracchiglione J, Meza N, Bangdiwala SI, Niño de Guzmán E, Urrútia G, Bonfill X, Madrid E. Graphical Representation of Overlap for OVErviews: GROOVE tool. Res Synth Methods. 2022;13:381-8. doi: 10.1002/jrsm.1557. PMID: 35278030.


13. Ferrer L, Gaillardin F, Cayuela A, Hernando C, Muñoz R, Sánchez N, Forero CG, Ronda E, Casabona J. Estado de salud de personas inmigrantes en Cataluña desde una perspectiva de género: Proyecto PELFI [Health status among immigrant in Catalonia from a gender perspective: PELFI project]. Gac Sanit. 2022;36:368-75.  doi: 10.1016/j.gaceta.2021.02.010. PMID: 33896656.


14. van der Gaag M, Heijmans M, Ballester M, Orrego C, Niño de Guzmán E, Ninov L, Rademakers J. Preferences Regarding Self-Management Intervention Outcomes of Dutch Chronically Ill Patients With Limited Health Literacy. Front Public Health. 2022;10:842462. doi: 10.3389/fpubh.2022.842462. PMID: 35646791.


15. van Wifferen F, Greuter MJE, Lissenberg-Witte BI, Carvalho B, Meijer GA, Dekker E, Campari C, Garcia M, Rabeneck L, Lansdorp-Vogelaar I, Senore C, Coupé VMH on behalf of the ICSN Colorectal Cancer Screening Working Group. Guidance for setting international standards on reporting longitudinal adherence to stool-based colorectal cancer screening. Prev Med. 2022;164:107187. doi: 10.1016/j.ypmed.2022.107187. PMID: 35963311.


16. Hernández-Leal MJ, Pérez-Lacasta MJ, Cardona-Cardona A, Codern-Bové N, Vidal-Lancis C, Rue M, Forné C, Carles-Lavila M  on behalf of the Pro-Share Group. Women’s preference to apply shared decision-making in breast cancer screening: a discrete choice experiment. BMJ Open 2022;12:e064488. doi: 10.1136/bmjopen-2022-064488. PMID: 36351714 


17. Ferrer L, González V, Martró E, Folch C, Saludes V, Muñoz R, Rodríguez V, Morales A, Meroño M, Morey F, Sanjosé S, Casabona J. High HIV/STI prevalence among cisgender men and transgender women sex workers attending community-based centres in Barcelona, Spain: The Sweetie Project. Int J STD AIDS. 2022;33:1045-1053. doi: 10.1177/09564624221116536. PMID: 36113447.